In addition, it has been found that Rb1 can improve metabolic disorders in high-fat diet-induced obese mice related to gut microbiota regulation, and oral administration of Rb1 significantly reduces serum LDL-c, TG, insulin, and insulin resistance index (HOMA-IR) in high-fat diet (HFD) mice. Here, INS is linked to Insulin resistance.